Indranil Bhattacharya

Indranil Bhattacharya possesses extensive experience in quantitative clinical pharmacology, currently serving as Executive Director of Marketed Products and Regions Quantitative Clinical Pharmacology at Takeda since July 2019. Previous roles include Senior/Executive Director at the Data Science Institute Franchise Lead, Section Head for Rare Disease, and Senior Director at Takeda. Indranil's prior experience includes positions as Director at Biogen, Director and Head of Clinical Pharmacology at Summit Therapeutics plc, and various roles at Pfizer, culminating in the role of Director in Clinical Pharmacology. Indranil began the professional journey as Principal Scientist at GSK. Educational credentials include a Ph.D. in Pharmaceutical Sciences from the University at Buffalo and a Bachelor of Pharmaceutical Sciences from Birla Institute of Technology, Mesra. Indranil's expertise encompasses early clinical development, model-based drug development, population pharmacokinetics, and interdisciplinary project contributions.